Sima Jing, Zhang Sarah X, Shao Chunkui, Fant James, Ma Jian-xing
Department of Medicine, The University of Oklahoma Health Sciences Center, 941 Stanton L. Young Blvd., BSEB 328B, Oklahoma City, OK 73104, USA.
FEBS Lett. 2004 Apr 23;564(1-2):19-23. doi: 10.1016/S0014-5793(04)00297-2.
Angiostatin is a potent angiogenic inhibitor. The present study identified a new activity of angiostatin: reducing vascular leakage, which is associated with diabetic macular edema, tumor growth and inflammation. An intravitreal injection of angiostatin significantly reduced retinal vascular permeability in rats with oxygen-induced retinopathy and in those with streptozotocin-induced diabetes, but not in normal rats. Consistent with its effect on permeability, angiostatin downregulated vascular endothelial growth factor (VEGF) expression in the retina in both the rat models but not in normal controls. These results suggest that the effect of angiostatin on vascular leakage is mediated, at least in part, through blockade of VEGF overexpression.
血管抑素是一种有效的血管生成抑制剂。本研究发现了血管抑素的一种新活性:减少血管渗漏,这与糖尿病性黄斑水肿、肿瘤生长和炎症相关。玻璃体内注射血管抑素可显著降低氧诱导性视网膜病变大鼠和链脲佐菌素诱导的糖尿病大鼠的视网膜血管通透性,但对正常大鼠无效。与其对通透性的作用一致,血管抑素在两种大鼠模型中均下调了视网膜中血管内皮生长因子(VEGF)的表达,但在正常对照中未下调。这些结果表明,血管抑素对血管渗漏的作用至少部分是通过阻断VEGF的过度表达介导的。